NO20071880L - Diagnostic Compounds - Google Patents

Diagnostic Compounds

Info

Publication number
NO20071880L
NO20071880L NO20071880A NO20071880A NO20071880L NO 20071880 L NO20071880 L NO 20071880L NO 20071880 A NO20071880 A NO 20071880A NO 20071880 A NO20071880 A NO 20071880A NO 20071880 L NO20071880 L NO 20071880L
Authority
NO
Norway
Prior art keywords
diagnostic compounds
processes
diagnostic
compounds
radiopharmaceuticals
Prior art date
Application number
NO20071880A
Other languages
English (en)
Inventor
Magne Solbakken
Alan Cuthbertson
Bente E Arbo
Alexander Gibson
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20071880L publication Critical patent/NO20071880L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Den gjeldende oppfinnelsen omfatter nye peptidbaserte forbindelser og bruk av disse for diagnostisk avbildning ved hjelp av positronemisjonstomografi (PET). Nærmere bestemt har oppfinnelsen å gjøre med bruk av slike peptidbaserte forbindelser som målvektorer som binder seg til reseptorer knyttet til angiogenese, særlig integrinreseptorer, for eksempel avß3-integrinreseptoren. Slike forbindelser kan altså brukes til diagnostisering eller behandling av, foreksempel alvorlig sykdom, hjertesykdom, endometriose, inflammasjonsrelatert sykdom, revmatoid artritt og Kaposis sarkom. Videre har den å gjøre med metoder og midler for produksjon av slike peptidbaserte forbindelser.
NO20071880A 2004-09-14 2007-04-13 Diagnostic Compounds NO20071880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
NO20071880L true NO20071880L (no) 2007-06-13

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071880A NO20071880L (no) 2004-09-14 2007-04-13 Diagnostic Compounds

Country Status (23)

Country Link
US (2) US7875701B2 (no)
EP (1) EP1791571B1 (no)
JP (1) JP4949251B2 (no)
KR (1) KR101243016B1 (no)
CN (1) CN101151054B (no)
AT (1) ATE404225T1 (no)
AU (1) AU2005283904B8 (no)
BR (1) BRPI0515175A (no)
CA (1) CA2578470C (no)
DE (1) DE602005008996D1 (no)
DK (1) DK1791571T3 (no)
ES (1) ES2312018T3 (no)
GB (1) GB0420344D0 (no)
IL (1) IL181529A (no)
MX (1) MX2007003019A (no)
NO (1) NO20071880L (no)
NZ (1) NZ553384A (no)
PL (1) PL1791571T3 (no)
PT (1) PT1791571E (no)
RU (1) RU2396272C9 (no)
SI (1) SI1791571T1 (no)
WO (1) WO2006030291A2 (no)
ZA (1) ZA200702700B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2719088T3 (es) * 2001-07-10 2019-07-08 Ge Healthcare Ltd Compuestos con base peptídica para localizar receptores de integrina
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
WO2008033561A2 (en) * 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
US8247534B2 (en) 2006-12-13 2012-08-21 Ge Healthcare As Synthesis of radiofluorinated peptide using microwave activation technology
US8241606B2 (en) 2006-12-18 2012-08-14 Ge Healthcare As Synthesis of a radiofluorinated peptide using photolabile protecting groups
EP2114464A2 (en) 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorination methods
BRPI0721424A2 (pt) * 2007-03-01 2014-03-25 Bayer Schering Pharma Ag Métodos de radiofluoração
CN101854957B (zh) * 2007-09-10 2013-05-22 通用电气健康护理有限公司 放射性氟化方法
EP2268609B1 (en) 2008-02-28 2013-01-30 GE Healthcare Limited Synthesis of a PEG-6 moiety from commercial low-cost chemicals
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
WO2011084763A1 (en) 2009-12-21 2011-07-14 Ge Healthcare Limited Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
CA2819347A1 (en) 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
KR20130124522A (ko) * 2010-12-09 2013-11-14 지이 헬쓰케어 리미티드 방사성 추적자 조성물
MX2013007364A (es) * 2010-12-21 2014-03-21 Ge Healthcare Ltd Uso de anilina en la radioestabilizacion de ligadura de oxima.
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
KR102668112B1 (ko) 2014-12-04 2024-05-23 지이 헬쓰케어 리미티드 방사성 약제로부터의 아세트알데히드의 제거 방법
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
ES2719088T3 (es) 2001-07-10 2019-07-08 Ge Healthcare Ltd Compuestos con base peptídica para localizar receptores de integrina
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
CA2578470C (en) 2015-09-01
JP2008516894A (ja) 2008-05-22
US20110117016A1 (en) 2011-05-19
DK1791571T3 (da) 2008-12-08
US7875701B2 (en) 2011-01-25
RU2007108762A (ru) 2008-10-27
PT1791571E (pt) 2008-11-19
HK1118713A1 (en) 2009-02-20
GB0420344D0 (en) 2004-10-13
RU2396272C9 (ru) 2010-12-10
AU2005283904B8 (en) 2012-02-23
CA2578470A1 (en) 2006-03-23
KR101243016B1 (ko) 2013-03-12
EP1791571B1 (en) 2008-08-13
MX2007003019A (es) 2007-08-07
EP1791571A2 (en) 2007-06-06
DE602005008996D1 (de) 2008-09-25
JP4949251B2 (ja) 2012-06-06
NZ553384A (en) 2011-02-25
WO2006030291A2 (en) 2006-03-23
AU2005283904A1 (en) 2006-03-23
KR20070053750A (ko) 2007-05-25
CN101151054A (zh) 2008-03-26
SI1791571T1 (sl) 2009-02-28
ES2312018T3 (es) 2009-02-16
CN101151054B (zh) 2014-09-24
ZA200702700B (en) 2008-09-25
RU2396272C2 (ru) 2010-08-10
BRPI0515175A (pt) 2008-07-08
US20080095701A1 (en) 2008-04-24
PL1791571T3 (pl) 2009-01-30
AU2005283904B2 (en) 2012-01-19
US8563600B2 (en) 2013-10-22
IL181529A0 (en) 2007-07-04
WO2006030291A3 (en) 2007-06-14
IL181529A (en) 2015-04-30
ATE404225T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
NO20071880L (no) Diagnostic Compounds
CR10157A (es) Compuestos químicos
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
AR110056A2 (es) Modulación de receptores quimiosensoriales y ligandos relacionados con los mismos
EA201070786A1 (ru) Бензофуропиримидиноны
HRP20120323T1 (en) Diarylhydantoin compounds
CR11861A (es) Compuestos organicos
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
DK2074120T3 (da) Tropan-forbindelser
CY1115919T1 (el) Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
WO2009035959A3 (en) Radiofluorination methods
UY30788A1 (es) Compuestos quimicos
EA200702352A1 (ru) Новые композиции нутрицевтиков
CY1110891T1 (el) Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη
DE602006009789D1 (de) Acetylenderivate
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
WO2008083191A3 (en) Radiofluorination methods
CR9578A (es) Inhibidores de la adenilato ciclasa soluble
NI200700232A (es) Uso de un compuesto
RU2005116452A (ru) Модификаторы для эвтектических силуминов

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA